Kevin T Strange is Chief Financial Officer of Inari Medical, Inc.. Currently has a direct ownership of 0 shares of NARI, which is worth approximately $0. The most recent transaction as insider was on Feb 19, 2025, when has been sold 67,502 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
n/a 12M change
Total Value Held $0

Kevin T Strange Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 19 2025
SELL
Disposition due to a tender of shares in a change of control transaction
-
67,502 Reduced 100.0%
0 Common Stock
Feb 04 2025
BUY
Grant, award, or other acquisition
-
21,102 Added 23.82%
67,502 Common Stock
Jan 01 2025
SELL
Payment of exercise price or tax liability
$52,938 $51.05 p/Share
1,037 Reduced 2.19%
46,318 Common Stock
Oct 01 2024
SELL
Payment of exercise price or tax liability
$42,295 $40.63 p/Share
1,041 Reduced 2.15%
47,355 Common Stock
Oct 01 2024
BUY
Grant, award, or other acquisition
-
5,695 Added 10.53%
48,396 Common Stock
KTS

Kevin T Strange

Chief Financial Officer
Irvine, CA

Track Institutional and Insider Activities on NARI

Follow Inari Medical, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NARI shares.

Notify only if

Insider Trading

Get notified when an Inari Medical, Inc. insider buys or sells NARI shares.

Notify only if

News

Receive news related to Inari Medical, Inc.

Track Activities on NARI